Qualisure News

Unique Thyroid Cancer Tests: New Hope Unveiled

A clinically useful and biologically informative genomic classifier for papillary thyroid cancer [2023]

Oliver Bathe: Qualisure Diagnostics Developing State-Of-The-Art Diagnostic Tests That Help To Personalize Cancer Care

From doctor to entrepreneur – Oliver Bathe from Qualisure Diagnostics

Improved Risk Stratification for Papillary Thyroid Cancer (PTC) using a genomic classifier informed by clinical features [2022]

2022 American Thyroid Association – Dr. Oliver Bathe

Qualisure Diagnostics: An AICE-Validate Success Story

Precision Oncology Test Thyroid GuidePx® Now Available From Qualisure Diagnostics

Molecular subgroups identified by machine learning enable accurate prognostication of papillary thyroid cancer [2021]

Dr. Cynthia Stretch (CSO) gave a podium presentation at the Annual Meeting of the Canadian Association of Surgical Oncologists